SCHEMBL5753848

SCHEMBL5753848

COCCN1C(C)=C(C(=O)O)[C@@H](c2cccc(C#N)c2Cl)C(C(=O)Oc2ncc[nH]2)=C1C

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NR3C2 P08235 1/20 0.38
PYGL P06737 10/20 0.34
PYGM P11217 10/20 0.34
KMT2A Q03164 3/20 0.33
LMNA P02545 2/20 0.32
SMN1; SMN2 Q16637 1/20 0.32
XDH P47989 1/20 0.32
CYP2C9 P11712 3/20 0.32
KDM4E B2RXH2 2/20 0.32
MEN1 O00255 2/20 0.32
CYP1A2 P05177 2/20 0.32
CYP3A4 P08684 2/20 0.32
CYP2C19 P33261 2/20 0.32
HIF1A Q16665 2/20 0.32
HSD17B10 Q99714 2/20 0.32
ALDH1A1 P00352 1/20 0.32
HPGD P15428 1/20 0.32
TP53 P04637 1/20 0.32
CYP2D6 P10635 1/20 0.32
TSHR P16473 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6951169 0.85 NR3C2 (0.43) NR3C2PYGLPYGMKMT2ALMNA
SCHEMBL5752638 0.81 PYGM (0.51) NR3C2PYGLPYGMKDM4E
SCHEMBL7307972 0.81 PYGM (0.51) NR3C2PYGLPYGMKDM4E
SCHEMBL5754356 0.81 PYGM (0.51) NR3C2PYGLPYGMKDM4E
SCHEMBL6952771 0.79 NR3C2 (0.42) NR3C2PYGLPYGMKMT2ALMNA
SCHEMBL8017636 0.77 PYGL (0.34) PYGLPYGMXDH
SCHEMBL5080218 0.76 PYGL (0.38) NR3C2PYGLPYGMKMT2ALMNA
SCHEMBL6951439 0.76 LMNA (0.44) NR3C2PYGLPYGMKMT2ALMNA
SCHEMBL9230837 0.74 PYGM (0.51) NR3C2PYGLPYGMXDH
SCHEMBL6949655 0.74 PYGL (0.44) NR3C2PYGLPYGMLMNASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0716081-B1 Highly selective process for the preparation of enantiomerically pure phenyl-substituted 1,4-dihydropyridine-3,5-dicarboxylic acid derivatives BAYER HEALTHCARE AG (DE) 2006-04-05 EP disclosed
EP-1443043-A2 Highly selective process for the preparation of enantiomerically pure phenyl-substituted 1,4-dihydropyridine-3,5-dicarboxylic acid derivatives Bayer HealthCare AG (DE) 2004-08-04 EP disclosed
EP-0716081-A1 Highly selective process for the preparation of enantiomerically pure phenyl-substituted 1,4-dihydropyridine-3,5-dicarboxylic acid derivatives BAYER AG (DE) 1996-06-12 EP disclosed